优化癌症疫苗使用生理学基础的药理动力学 (PBPK) 模型.
bioRxiv : the preprint server for biology
|December 3, 2025
概括
一个新的生理学基础的药理动力学 (PBPK) 模型整合了免疫运输以优化癌症疫苗设计. 这个工具有助于个性化抗癌疫苗接种策略,通过根据个体瘤因素预测最佳的分娩时间.
科学领域:
- 免疫学 免疫学 免疫学
- 药理动力学 药理动力学
- 计算生物学 计算生物学
背景情况:
- 基于抗原的瘤疫苗需要辅助剂进行免疫刺激.
- 了解抗原运输和免疫细胞动态对于有效的疫苗设计至关重要.
- 目前的策略受限于对复杂的免疫相互作用的理解不足.
研究的目的:
- 开发一种针对抗原疫苗接种的多尺度生理基药动力学 (PBPK) 模型.
- 为了整合系统循环,淋巴连接和免疫细胞激活.
- 为了优化癌症疫苗设计和输送策略.
主要方法:
- 开发了一个多尺度的隔间PBPK模型.
- 集成的动脉,静脉,淋巴流和器官特定网络.
- 模拟了抗原,抑制因子和APC激活的时空分布.
主要成果:
- 该模型准确地复制了抗原分布和免疫细胞激活.
- 疫苗的有效性对瘤产生的抗原和抑制因素敏感.
- 早期的疫苗接种表明免疫反应得到增强.
结论:
- 该PBPK模型提供了优化癌症疫苗管理的见解.
- 它可以根据瘤特征预测患者特定的疫苗接种策略.
- 该模型作为开发数字双胞胎的基础,用于个性化癌症疫苗接种.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
309
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
309
Pharmacokinetic Models: Overview
1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Model Approaches for Pharmacokinetic Data: Physiological Models
236
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
236
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
Model Approaches for Pharmacokinetic Data: Compartment Models
504
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
504
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
250
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
250


